Intervention Review

D-penicillamine for primary sclerosing cholangitis

  1. Sarah Louise Klingenberg1,*,
  2. Wendong Chen2

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 14 SEP 2005

DOI: 10.1002/14651858.CD004182.pub3

How to Cite

Klingenberg SL, Chen W. D-penicillamine for primary sclerosing cholangitis. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD004182. DOI: 10.1002/14651858.CD004182.pub3.

Author Information

  1. 1

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Cochrane Hepato-Biliary Group, Copenhagen, Denmark

  2. 2

    Toronto Health Economics and Technology Assessment Collaborative (THETA), University of Toronto, Departments of Health Policy Management and Evaluation, and Pharmacy, Toronto, Ontario, Canada

*Sarah Louise Klingenberg, Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, DK-2100, Denmark. slk@ctu.rh.dk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

  1. Current Version

    D-penicillamine for primary sclerosing cholangitis

    Sarah Louise Klingenberg and Wendong Chen

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD004182.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    D-penicillamine for primary sclerosing cholangitis

    SL Frederiksen and W Chen

    Article first published online: 19 OCT 2005 | DOI: 10.1002/14651858.CD004182.pub2

  2. Version 1

    D-penicillamine for primary sclerosing cholangitis

    SL Frederiksen and W Chen

    Article first published online: 14 AUG 2002 | DOI: 10.1002/14651858.CD004182